Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The metabolic and cardiovascular benefits of GLP-1 receptor agonists significantly outweigh this temporary cosmetic concern
uninsured patients often pay higher out-of-pocket rates, while those with compatible insurance may see reduced costs
The SURMOUNT-1 study was a placebo-controlled 72-week trial in obese subjects that randomized 2,539 participants without diabetes into four equally large study arms with placebo or one of the three tirzepatide doses (5, 10, or 15 mg once weekly)
62% with type 2 diabetes)
This product works really well
Well-controlled hypothyroidism shouldnt significantly impact how well Wegovy works
US$ 27.38
US$ 21.01
US$ 24.65
US$ 22.98
US$ 24.55
US$ 24.94
